Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Zai Lab Limited ADR shares valued at $288,540 were sold by Chen Yajing on Jun 02 ’25. At $30.00 per share, Chen Yajing sold 9,618 shares. The insider’s holdings dropped to 17,429 shares worth approximately $0.72 million following the completion of this transaction.
Also, Chen Yajing purchased 9,618 shares, netting a total of over 288,540 in proceeds.
Before that, Du Ying had sold 50,000 shares from its account. In a trade valued at $1,428,650, the Chairperson & CEO traded Zai Lab Limited ADR shares for $28.57 each. Upon closing the transaction, the insider’s holdings decreased to 50,000 shares, worth approximately $19.87 million.
As published in their initiating research note from Scotiabank on March 07, 2025, Zai Lab Limited ADR [ZLAB] has been a Sector outperform and the price target has been revised to $55. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of December 14, 2023, Morgan Stanley has initiated its “an Overweight” rating for ZLAB. Earlier on August 10, 2023, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for ZLAB stock.
Analyzing ZLAB Stock Performance
During the last five days, there has been a surge of approximately 14.75%. Over the course of the year, Zai Lab Limited ADR shares have jumped approximately 58.08%. Shares of the company reached a 52-week high of $41.44 on 06/11/25 and a 52-week low of $23.82 on 01/15/25.
Support And Resistance Levels for Zai Lab Limited ADR (ZLAB)
According to the 24-hour chart, there is a support level at 40.47, which, if violated, would cause prices to drop to 39.55. In the upper region, resistance lies at 41.88. The next price resistance is at 42.37. RSI (Relative Strength Index) is 75.75 on the 14-day chart, showing overbought technical sentiment.
